"In conclusion, Wever’s group writes, 'improvements in renal function after tenofovir cessation is variable and incomplete, particularly in patients with more gradual decline in GFR who are not receiving a protease inhibitor.' They also suggest using a GFR below 90, as opposed to a CKD-defining GFR below 60, when determining whether to discontinue tenofovir treatment 'to avoid permanent renal dysfunction.'"
Read more in POZ, March 3, 2010.
0 comments:
Post a Comment